Bsenexus Terminal Open in Bsenexus App →
MATERIAL_EVENT BSE: 524816

Natco Pharma Ltd

Natco Pharma Ltd - 524816 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 12, 2026 for V C Nannapaneni